Search Results | Midlothian Science Zone

Cambrex

Cambrex acquired Avista in 2019 following previous acquisition of Solid Form Solutions, a global organisation providing drug substance, product and analytical services across the entire drug lifecycle.

£1.1m study could pave way for therapies to repair spinal cord

A European team coordinated by the University of Edinburgh have been awarded £1.1 million to investigate how zebrafish are able to repair and replace damaged nerve cells.

Crohn’s and colitis study probes relapse triggers

Patients from across Scotland and England with Crohn’s disease and ulcerative colitis are being invited to take part in a study to better understand the diseases.

Diabetes study to spot linked health problems

A major research initiative using cutting edge data analysis techniques to better understand health complications experienced by people with diabetes has been launched.

Food chain start-up sinks teeth into £2m funding deal

A specialist in food chain traceability born out of the Entrepreneurial Spark hatchery has received a seven-figure funding injection.

Chancellor opens imaging suites

Two advanced medical scanners have been installed as part of a £14 million makeover of research imaging facilities at the University of Edinburgh.

Experts join £250m dementia initiative

The University of Edinburgh is to join five other institutions to form the UK Dementia Research Institute.

Head of College gains Royal assent for distinguished academic post

Professor Sir John Savill, Head of the College of Medicine and Veterinary Medicine, has been appointed to the Regius Chair of Medical Science at the University of Edinburgh.

Study reveals pollution risk for heart health

Tiny particles such as those released from vehicle exhausts can pose a health risk, a University of Edinburgh study suggests.

Brain cancer study reveals therapy clues

Researchers have pinpointed two key molecules that drive the growth of an aggressive type of adult brain cancer.

University of Edinburgh spearheads China diabetes care model

A cutting-edge diabetes research and treatment centre will be established in a major Chinese city where one in ten people has the disease.

Coffee cuts liver cancer risk, study suggests

Coffee drinking may help to protect people from the most common form of primary liver cancer, research by the Universities of Edinburgh and Southampton suggests.

Censo Biotechnologies and Leeds University collaborate to create stem cells from cancer tissue

Scientists at Censo Biotechnologies are developing a new approach to cancer research using stem cell technology.

Experts call for clampdown on medical tourism

An international group of leading experts has called for tighter regulation of so-called stem cell tourism.

Study reveals cells can be reprogrammed to repair severe liver injury

A new study has revealed that bile duct cells can switch to become normal liver cells to help repair the liver after severe damage.

Dementia prevention hopes raised by major scan study

Dementia researchers are to receive a £1.9 million investment to identify the earliest brain changes associated with conditions such as Alzheimer’s disease.

Fish reveal clues to healing spinal cord injuries

Fresh insights into how zebrafish repair their nerve connections could hold clues to new therapies for people with spinal cord injuries.

Cell study reveals how body detects early signs of cancer

Fresh insights into how cells detect damage to their DNA – a hallmark of cancer – could help explain how the body keeps disease in check.

Brain study reveals clues to treating Fragile X syndrome

Scientists have discovered how the brain can self-correct disruptions in processing, pointing the way towards possible new treatments for autism and intellectual disability.

Lung diseases targeted by £7m initiative

Experts have received £7 million to launch a research initiative focused on reducing the impact of lung diseases worldwide.

Immune study points to lung therapies

Fresh insight into how the immune system keeps itself in check could lead to new ways of fighting chronic lung disease.

Gold specks raise hopes for better cancer treatments

A tiny medical device containing gold specks could boost the effects of cancer medication and reduce its harm, research suggests.

£3 million boost for cancer centre

The £3 million investment will help fund pioneering research at the Edinburgh Experimental Cancer Medicine Centre (ECMC) for the next five years.

Medical camera sees through the body

Scientists in Edinburgh have developed a camera that can see through the human body.

Gene study sheds light on middle-age sight loss

Chemical changes in the eye that can lead to blindness have been identified by scientists, and presented at conference in Edinburgh.

Brain aging controlled by gene programme

Brain scientists have identified a genetic programme that controls the way our brain changes throughout life.

Cell-based therapies could be boosted by new antioxidant

Cell therapies being developed to treat a range of conditions could be improved by a chemical compound that aids their survival, research suggests.

Synpromics wins ‘best emerging UK synthetic biotech company’ at OBN Awards

Synpromics, a leader in gene control, was awarded Best Emerging UK Synthetic Biotech Company at the 9th Annual OBN Awards.

Nerve study shows how cells adapt to repair damage

Genetic processes that allow cells to transform so they can mend damaged nerves have been identified by scientists.

Worms aid quest for asthma therapies

People with asthma could be helped by a new therapy based on a molecule produced by parasitic worms, research suggests.

Building for the future of Regenerative Medicine in Edinburgh

The Centre for Regenerative Medicine (CRM) is marking the beginning of construction of the Centre of Tissue Repair and together they will form the Institute for Regeneration and Repair.

Heart therapy hope as drug blocks muscle scarring

A potential treatment to prevent deadly muscle scarring that contributes to chronic heart failure has been uncovered by scientists, led by University of Edinburgh.

Dementia healthcare needs a revolutionary rethink

Clinical services for people at high risk of dementia need a radical rethink in line with the latest scientific understanding of the condition, say leading researchers.

Type 2 diabetes linked to shorter lifespan

Type 2 diabetes is linked to lower life expectancy regardless of a person’s socioeconomic status, a Scotland-wide study suggests.

Immune finding raises allergy treatment hopes

Edinburgh researchers have identified a previously unknown mechanism by which the responses of key cells of the immune system are regulated.

Brain cell advance brings hope for CJD

Scientists have developed a new system to study Creutzfeldt-Jakob disease in the laboratory, paving the way for research to find treatments for the fatal brain disorder.

Brain study sheds light on how dementia spreads

Insights into how a key chemical disrupts brain cells in a common type of dementia have been revealed by scientists in a study, co-led by the University of Edinburgh.

Quest for new drugs could be helped by cell discovery

Scientists have made a key discovery that could speed up the production of cells in the lab for studying diseases such as multiple sclerosis and Parkinson’s disease.

£3.8m brings lung imaging devices closer to clinic

The investment will enable researchers to further develop systems that could revolutionise how lung diseases are investigated, diagnosed and treated.

Two simple tests could help to pinpoint cause of stroke

Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Ingenza embarks on ConBioChem collaboration

Roslin-based Ingenza has joined forces with leading universities and industrial partners to participate in the ConBioChem collaboration.

DNA study casts light on cell division mystery

Scientists have solved a longstanding puzzle of how cells are able to tightly package DNA to enable healthy cell division.

Lab-grown eggs could aid fertility treatments

Human eggs have been fully grown in a laboratory, in a move that could lead to improved fertility treatments.

£1.7M of Innovate UK funding will help tackle silent killer that could affect one in four Scots

Funding will help develop new treatments for the commonest cause of chronic liver disease.

Liver study insights into hard-to-treat diseases

Edinburgh researchers have discovered a potential new target for the treatment of a type of liver disease that affects the bile ducts.

Landmark stroke study could hold key to new therapies

Fresh insights into the biological causes of stroke could pave the way for new therapies, following a study carried out by researchers, including experts from the University of Edinburgh’s Usher Institute.

Hundreds of genes linked to intelligence in global study

More than 500 genes linked to intelligence have been identified in the largest study of its kind, carried out by the Universities of Edinburgh and Southampton, and Harvard University.

Cancer patients’ pain eased by simple bedside chart

Patients with cancer could benefit from a simple bedside system to manage their pain, a study suggests.

Healthcare research centre boosts Edinburgh-Zhejiang alliance

Medical research will be translated into technologies to improve healthcare as part of a new collaboration between Chinese researchers and the University of Edinburgh.

Malaria study reveals gene variants linked to disease

In a study of more than 5,000 Kenyan children, Edinburgh researchers with colleagues from Oxford, Kenya and Mali examined two variations, or mutations – known as Sl2 and McCb – in a gene called CR1.

Cancer patients set to benefit from world's largest surgery study

Improved care for patients undergoing cancer surgery is the focus of a pioneering worldwide study with research led by the Universities of Edinburgh, Birmingham and Warwick.

Quotient inaugurates new campus on Edinburgh outskirts

Transfusion diagnostics company, Quotient, has official opened its state-of-the-art Allan-Robb Campus within the Scottish Enterprise Biocampus in Midlothian.

Bowel disease study points to new therapies

Scientists at the University of Edinburgh looked for factors that might be associated with disease flare-ups by testing blood samples from almost 100 people with IBD.

£53m to probe genetic links to health and disease

Research into human genetics has received a £53 million boost from the Medical Research Council (MRC).

£4m bid to find therapies that prompt tissues to repair

Stem cell scientists are to join forces with doctors to investigate methods of promoting tissue repair in the liver, lungs and joints.

Artificial Intelligence improves stroke and dementia diagnosis in brain scans

New software, created by scientists at Imperial College London and the University of Edinburgh, has been able to identify and measure the severity of small vessel disease, one of the commonest causes of stroke and dementia.

Aspirin’s anti-cancer effects revealed

Researchers at University of Edinburgh have shed light on how taking aspirin can help to stave off bowel cancer.

Stem cell therapy mends broken hearts

Heart attack survivors are benefiting from a pioneering therapy involving stem cells harvested from their own blood.

Drug hope for dementia and stroke

CRM scientists have uncovered a potential approach to treat one of the commonest causes of dementia and stroke in older people.

CALCIVIS raises £3.15m to fund PMA approval of CALCIVIS® Imaging System ahead of a planned US launch

CALCIVIS, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces it has closed a £3.15 million equity funding round from existing investors Archangel Investors, Julz and the Scottish...

Superbug discovery renews hope for antibiotic treatment

Bacteria that were thought to be resistant to a powerful antibiotic may be susceptible to treatment after all, research has found.

Censo Biotechnology awarded SMART funding to develop new stem cell technology

Roslin-based Censo Biotechnologies been awarded a Scottish Enterprise SMART:SCOTLAND grant to undertake an innovation project that will develop new methods to create stem cells for medical research.

Consortium secures Innovate UK funding for new antibiotics

Midlothian-based industrial biotechnology company Ingenza is working with the National Physical Laboratory and the University of Plymouth to develop a design and manufacturing platform for the production of a new family of antibiotics.

Malaria parasites adapt to mosquito meal times

Malaria parasites have evolved to be most infectious at the time of day when mosquitoes feed, to maximise the chance of being spread, research shows.

Fish immune cells lend clues to spinal repair

Fresh insights into how zebrafish repair their damaged nerve connections could aid the development of therapies for people with spinal cord injuries.

Censo Biotechnologies announce new funding for COPD research

Censo Biotechnologies has announced that it is extending its stem cell based research platform to support the development of treatments for Chronic Obstructive Pulmonary Disease (COPD).

Scotland’s Health Research and Innovation Ecosystem directory launched

The new directory called Scottish Health Research and Innovation Ecosystem launched today at the annual Life Science Scotland conference in Glasgow.

Cambrex to acquire Avista Pharma Solutions

Cambrex to acquire Avista Pharma Solutions, adding early stage API and finished dosage form development and testing services to its global contract development and manufacturing network.

Stem cell bid set to tackle osteoarthritis

The research focuses on harnessing the capabilities of the patient’s own cells to repair damaged joint tissue.

DNA may predict potential lifespan, study finds

Scientists say they can predict whether a person can expect to live longer or die sooner than average, by looking at their DNA.

Amprologix secures funding to develop new antibiotic with Ingenza

Amprologix has been awarded a £1.2 million contract from the UK Department of Health and Social Care to accelerate the development and scale up its lead antibiotic candidate.

Protein study may aid understanding of diseases

Scientists have shed light on a biological process that helps the production of healthy cells, which may aid understanding of neurological diseases and other conditions.

Drug resistance effort aided by sewage survey

Efforts to monitor the spread of antibiotic resistance worldwide could be transformed with a map created using data from analysis of sewage samples.

Parkinson’s patients could be helped by fresh insights from zebrafish study

Research using zebrafish has revealed how key brain cells that are damaged in people with Parkinson’s disease can be regenerated.

Tools to watch cells eating could aid diagnoses

Scientists have developed a new imaging technology to visualise what cells eat, which could aid the diagnosis and treatment of diseases such as cancer.

Immune study sheds light on vitamin D effects

Scientists have uncovered fresh insights into how vitamin D affects the immune system and might influence susceptibility to diseases such as multiple sclerosis.

Immune cells key to predicting cancer outcomes

Scientists have identified key changes in immune cells within cancerous tumours that could help improve the development of treatments.

DNA managed like climbing rope to avoid knots

A process that cells use to unravel knotted strands of DNA – resembling a method used to control climbing ropes – has been uncovered by scientists.

Immune find could aid stem cell therapy quest

A discovery of how stem cells are protected from viruses could inform the development of therapies for use in medicine, research suggests.

Edinburgh inflammatory bowel disease hotspot

Researchers find that Edinburgh has some of the highest known rates of inflammatory bowel disease in the world and figure is expected to rise.

Cell therapy safe for liver patients, trial shows

Liver disease patients could one day benefit from a new cell therapy that has just completed its first clinical trial.

£2.75 million spinout deal offers dialysis hope

An Edinburgh spinout whose innovative products could save kidney patients’ lives has raised £2.75m in a new funding deal.

Alzheimer’s memory discovery

Scientists at the Universities of St Andrews and Edinburgh have discovered the functions of the area of the brain in which Alzheimer’s begins, offering hope for the development of future treatments.

Gut cells are gatekeepers of infectious brain diseases

New insights into infectious brain conditions help to explain why some people – and animals – are more at risk than others.

Zebrafish aid quest to treat disease

Tropical fish are helping scientists to investigate how to stop inflammation in the body before it causes damage to healthy tissues.

Scottish Government announces agriculture champions

The Scottish Government has appointed four Agriculture Champions to advise on the development of a strategy for the sector.

A humanized phenotypic screening platform for chronic pain

Physiologically relevant human models of chronic pain are essential to developing new therapeutics and overcome poor translation between animal studies and the clinical setting. Learn more in an upcoming webinar on stem cell-based pain and CNS drug discov...

Genetic insights into inflammatory bowel disease

An international study led by scientists at The Roslin Institute highlights gut macrophage dysregulation as a key process leading to Inflammatory Bowel Disease.

Insights into the ageing immune system

Scientists at The Roslin Institute uncover the effects of ageing on spleen structure and function.

Immune discovery points to therapies to improve stroke recovery

A study led by Dr. Barry McColl, of The Roslin Institute, shows that having a stroke damages immune cells as well as affecting the brain.

Study targets virus linked to birth defects

Fresh insights into how a common virus replicates could pave the way for new therapies to stop its spread.

Digital Academy set to transform NHS care

The University of Edinburgh is joining forces with Imperial College London and Harvard Medical School to launch a NHS Digital Academy.

New method for understanding neurodegenerative diseases

A large scale analyses of neuronal proteins sheds light on the mechanisms underlying neurodegenerative disease.

Significant research grant awarded for Type 1 diabetes research

Professors Helen Colhoun and Paul McKeigue of the MRC Centre for Genomic & Experimental Medicine receive award from Diabetes UK for Type 1 diabetes research.

Capsule could revolutionise medical and veterinary sector

Researchers from Heriot-Watt University and The Roslin Institute are developing a capsule that could cut out the need for repeated injections and help fight infectious diseases, such as tuberculosis.

Volunteers sought in hunt for genes linked to severe flu cases

Volunteers are being invited to take part in a flu study to understand why some people are more susceptible to the virus than others.

A biological solution to carbon capture and recycling?

Scientists at the University of Dundee, working with Sasol UK and Ingenza Ltd, have discovered that E. coli bacteria could hold the key to an efficient method of capturing and storing or recycling carbon dioxide.

INC Research/inVentiv Health becomes Syneos Health

INC Research, based in the Fleming Building at Edinburgh Technopole, has merged with inVentiv Health to form one global company - Syneous Health, purpose built for biopharmaceutical acceleration.

Cabinet Secretary visits Edinburgh Genomics at The Roslin Institute

Shona Robison MSP, Cabinet Secretary for Health and Sport, visits Edinburgh Genomics at The Roslin Institute.

£2.4m boost for brain tumour research

Scientists at Edinburgh are to receive £2.4 million to find new ways to tackle brain tumours.

Food supplies rethink could help avoid dietary crisis in India

Researchers from the University of Edinburgh found that closing the gap between India’s food and nutrition supplies and its population growth will require a combination of measures.

Spinout deal offers dialysis hope

An Edinburgh spinout whose innovation could save kidney patients’ lives is the first to benefit from a new funding deal.

3D simulation shows benefits of brain cooling

Fresh insight into how the brain responds to medically induced cooling could inform treatments for head injuries and conditions such as stroke.

£11.6 million for university research and innovation

Scottish universities are getting a funding boost to help them compete for research projects together with industry partners.

Rugby star pledges new funds for drug screening research

The My Name'5 Doddie Foundation has pledged £250K to the University of Edinburgh's Euan MacDonald Centre for a drug screening programme.

Life Sciences Scotland appoints two MSPs to their Industry Leadership Group

Life Sciences Scotland welcomes new co-chair, Ivan McKee the Minister for Trade, Investment and Innovation and Joe Fitzpatrick, Minister for Public Health, Sport and Wellbeing.

Codebreaker’s legacy could speed diagnosis

Unpublished work by Second World War codebreaker Alan Turing could aid development of better tests for early diagnosis of cancer and emerging diseases.

Tumour immune cells could aid cancer therapies

A pioneering technique designed to identify the range of immune cells in a tumour could speed the development of cancer treatments.

New award boosts research into intestinal disease

New research project could help develop treatments for people with Crohn’s disease or other intestinal diseases by identifying what molecules macrophages produce supporting gut lining development.

University of Edinburgh part of VALUE-Dx partnership to fight AMR

VALUE-Dx is an Innovative Medicines Initiative consortium project involving the University of Edinburgh, that will combat antimicrobial resistance and improve patient outcomes.

Crohn's disease research to benefit from £1.8m funding

An international philanthropic trust has awarded significant funding to aid scientists' understanding of the currently incurable condition known as Crohn's disease.

Cancer study to ease plight at advanced stages of illness

University of Edinburgh Researchers awarded almost £1m from the Medical Research Council, part of UK Research and Innovation, to enable a cancer study.

Cambrex to double size of Edinburgh solid form screening facility

Cambrex, a world-leader in providing solid form development services for drug substance and drug product, is doubling their footprint at Edinburgh Technopole.

Space Agency launches Lyme app

A new project that aims to prevent the occurrence of Lyme disease in the Northern Hemisphere launches in Scottish Highlands.

Funding for rural innovation

A digital system to monitor gluten-free oats is among several innovative SRUC projects to share in nearly £275,000 of Scottish Government funding.

J.K. Rowling donates £15m to MS research

The author J.K. Rowling has donated £15.3m to the University of Edinburgh to help improve the lives of people with multiple sclerosis (MS) and similar conditions.

Berry healthy

The trend for fermented foods and non-alcoholic soft drinks is being embraced by a Scottish social enterprise with the help of consultants from SRUC.

Seaweed is making waves in Scotland says top food & drink development team

Seaweed is one of the most popular products in development for our SAC Consulting Food & Drink team as consumer trends drive demand for food with health and nutritional benefits.

Roslin scientists support work to tackle coronavirus

Researchers at The Roslin Institute are taking part in global efforts to better understand and develop therapies for the ongoing coronavirus infection.

Steroids could impair defence against coronavirus

Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised.

Protein has crucial role in hardening of arteries

Research led by Roslin scientists highlights a key protein linked to the formation of hardened arteries and the mechanisms behind this.

Lung tissue forms immune cell hubs when needed

Research uncovers how lung tissue is remodelled to support an immune response to influenza.

Scottish immunotherapy company secures over £6m in funding

TC BioPharm has secured more than £6.25 million to press ahead with the development of innovative cancer treatments.

Experts at the University of Edinburgh win support from Garfield Weston Foundation to tackle rising threat of antibiotic resistance

Experts are to tackle one of the biggest health challenges facing society - the ability of common infections to resist drug treatment - in a new facility being created at the University's King's Buildings campus.

TC Biopharm gets €4m Horizon2020 grant

TC BioPharm has been selected for EU Horizon 2020 Funding to progress novel, mass-market cell therapies to clinical trial.

Supporting the rural economy

Research on food, plants and animals has generated £600 million of economic benefit and supported over 2,800 Scottish jobs, new analysis has shown.

Scientists support African drug resistance fight

Edinburgh researchers have contributed to a Zimbabwean initiative to tackle the threat of growing resistance to antibiotics.

Synpromics announces collaboration with UCL to develop revolutionary gene therapy for Parkinson’s Disease

Synpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system (CNS), to develop a gene therapy for Parkinson’s disease.

Algae could feed and fuel planet with aid of new hi-tech tool

Vast quantities of medicines and renewable fuels could be produced by algae using a new gene-editing technique, a study suggests.

University of Edinburgh staff recognised in New Year’s Honours

Many congratulations to the University of Edinburgh staff members who have been recognised in the Queen’s New Year’s Honours list.

Solid Form Solutions acquired by Avista Pharma Solutions

Avista Pharma announce it has completed the acquisition of Solid Form Solutions, located at Edinburgh Technopole, Midlothian.

Synpromics announces new partnership with UCL to develop novel gene therapies for blood-based disorders

Synpromics Ltd, the leader in gene control, announces a collaboration with UCL Great Ormond Street Institute of Child Health, to develop novel gene therapies for pathologies affecting the haematopoietic system.

TC BioPharm and the NIPRO Corporation announce strategic programme co-developing a novel gamma-delta CAR-T product to treat cancer

TC BioPharma, the Scottish biotechnology firm, has teamed up with Japanese pharmaceutical company, NIPRO Corporation, to develop a new type of cancer therapy.

Miles Briggs MSP visits Edinburgh Genomics at The Roslin Institute

Miles Briggs MSP visited The Roslin Institute and the Edinburgh Genomics next generation sequencing facility to underline his support for advanced genomics technologies.

Meal times may be key to managing malaria

Malaria infections might be brought under control by managing the eating habits of infected people or animals, according to a new study.

Egg study may improve food safety

Scientists are leading research to minimise the spread of bacterial diseases such as E.coli in eggs.

Dolly scientist backs drive to tackle Parkinson’s

Professor Sir Ian Wilmut – who led the team that created Dolly the sheep – has backed an initiative to tackle Parkinson’s disease, after being diagnosed with the condition.

TC BioPharm wins Life Sciences Company of the Year 2018

TC BioPharm won the "Life Science Company of the Year" last night at the Business Insider Made in Scotland Awards 2018.

Relocation reflects ambitious growth plans

Leading industrial biotech company Ingenza Ltd announces relocation to Roslin Innovation Centre, a £30 million, multi-purpose innovation hub on the University of Edinburgh’s Easter Bush Campus.

TC BioPharm broadens CAR-T drug pipeline

TC BioPharm Ltd (TCB) and Scotia Biologics announce a strategic collaboration to co-develop novel proprietary tumour-specific antibodies for TCB’s CAR-T platform.

Synpromics awarded £1.9m grant from Scottish Enterprise

Synpromics Ltd, the leader in gene control, today announced it has been awarded a £1.9m research and development grant from Scottish Enterprise.

Partnership boosts cystic fibrosis therapy bid

Experts at the University of Edinburgh are teaming up with leading figures from industry to advance development of a gene therapy for cystic fibrosis.

Edinburgh's Legends Life Sciences week starts 13 August

VisitScotland's Legends campaign is a national digital campaign focusing on Scotland's 12 key sectors, including Life Sciences. #IdeasBecomeLegend

Edinburgh secures prestigious ‘6th WORLD ONE HEALTH CONGRESS’

Scotland’s capital will host the esteemed 6th WORLD ONE HEALTH CONGRESS in 2020, following a successful competitive bid process against other European cities.

Imaging advance to speed quest for cell therapies

Cancer treatments that involve transplanting cells into patients could move forward faster thanks to a new imaging system.

Stem cell liver implants show promise

Liver tissue grown from stem cells could one day replace the need for transplants, research suggests.

Ingenza takes a stake in new spin-out company Amprologix

Ingenza, a leader in the application of industrial biotechnology and synthetic biology, is pleased to announce that it has become a stakeholder in Amprologix, a spin-out company from the University of Plymouth.

Scientific breakthrough could explain how superbugs rapidly evolve

New study reveals how bacteria evolve rapidly and will help to understand how they become antibiotic resistant.

Global bid to decode DNA of all life on Earth

Experts have joined a bid to examine the genetic code of all 1.5 million animals, plants and other forms of life on Earth.

TC BioPharm partners with Trinity College Dublin to develop V delta 1 γδ T cell-based cancer treatments

Immunotherapy company TC BioPharm partners with Trinity College Dublin to develop V delta 1 γδ T cell-based cancer treatments with clinical programme scheduled to commence late 2019.

TC BioPharm creates allogeneic cell banks for CAR-T cancer therapy products

The first completed bio-banks will be used to develop more cost-effective, safe and efficacious cancer treatments.

Edinburgh Genomics sequencing lab awarded international quality stamp

Edinburgh Genomics has received an accreditation to mark the quality of its genome sequencing services.

£6m boost to train doctors in cancer research

A multimillion pound boost to transform training for doctors undertaking cancer research seeks to retain women scientists in the field.

Skills boost for Scotland’s Life and Chemical Sciences Sector

Employers are being offered help to develop talent through a new online portal.

Research to probe how Covid-19 affects people

Dr Kenneth Baillie, is leading a major new research project that seeks to increase our understanding of COVIDー19 and its impact on the body, with £4.9m from the UK Government’s rapid response call.

Cat’s treatment highlights risk of rare infection

Treatment of a rare but potentially serious fungal disease in a cat has highlighted the risk of similar infections in animals and their owners.

Scottish biotech firm to offer free COVID-19 testing for frontline NHS workers

Roslin-based CensoBio is the first Scottish lab to take part in the COVID-19 Volunteer Testing Network and will provide same-day results.

Midlothian design engineer is only UK finalist in global challenge to invent new ventilator

Locally based design engineer is the only UK finalist in a global challenge to invent a new ventilator to help Covid-19 sufferers.

New centre boosts Scottish biomedical sector

A new research centre to develop and manufacture medical devices in Scotland has been launched.

COVID-19 antibody test developed at Midlothian BioCampus

Midlothian based scientists Quotient Limited demonstrate a coronavirus antibody test and analysis for the presence of SARS-Cov2, the virus behind Covid-19, using their MosaiQ™ automated testing platform designed for rapid results in transfusion diagnostic...

Researchers develop mathematical model to predict the spread of airborne diseases

Researchers from Heriot-Watt University and the University of Edinburgh have developed a mathematical model of droplet migration.

Caffeine delivers insight into drug resistance

The management of fungal infections in plants and humans could be transformed by a breakthrough in understanding how fungi develop resistance to drugs.

Face coverings can cut risk of coronavirus spread

A range of face masks could all potentially help reduce Covid-19 transmission, a study shows.

Chicken study probes resistance to food bug

Receiving gut microbes from resistant chickens does not lessen chickens’ susceptibility to bacterium that causes food poisoning.

Former Apple adviser to meet Scottish female founders in California trade mission

Ron Weissman, a leading global tech sector figure, will meet Scottish-based female company founders including those from within Midlothian Science Zone.

Tackling Toxoplasmosis: A new animated film about the world’s most successful parasite

Moredun, in collaboration with the University of São Paulo, UKRI and FAPESP, have released an engaging animation to help inform and educate about a parasite called Toxoplasma gondii.

Widely available antibiotics could target common strains of superbug

A combination of antibiotics and a drug used to treat kidney infections could effectively treat a common superbug and limit the impact of antibiotic resistance.

Gut worms may hinder the spread of prions to the brain

Study of an infectious brain condition that destroys nerve cells helps to explain why some individuals may be at more risk than others.

Sepsis treatment quest focuses on genes

Pioneering research is to focus on the role genes play in determining how likely people are to die from infection in the hope it will speed the search for new medicines.

Gene study shows couples have similar lifespan

People tend to unwittingly choose a life partner who is likely to have a comparable life expectancy, research suggests.

Hen eggs set to crack future drug production

Chickens that are genetically modified to produce human proteins in their eggs can offer a cost-effective method of producing certain types of drugs, research suggests.

Long-read DNA analysis can give rise to errors

Advanced technologies that read long strings of DNA can produce flawed data that could affect genetic studies, experts warn.

EPP Ltd

Edinburgh Pharmaceutical Processes (EPP) Ltd is a GLP contract research organisation supporting agrochemical, human and animal pharmaceutical and industrial chemical sectors.

EPP Ltd - Synthetic Organic Chemist

Dr Joe Watson is a Synthetic Organic Chemist, part of the R&D Team with EPP Ltd, and enjoys work both in the lab and 'in the zone'.

One (Reproductive) Health

A study in human cells and tissues collected from cattle shows that the gene-regulating molecule miR-96 could be key for establishing and sustaining pregnancy.

University of Edinburgh to play pivotal role in creating Data Capital of Europe

The University of Edinburgh will be a key partner in a major initiative that seeks to make Edinburgh and its surrounding region the European leader for applying data science to products and services.

Roslin Innovation Centre opens its doors to gene control experts Synpromics Ltd

Roslin Innovation Centre, the new gateway development at the University of Edinburgh’s Easter Bush Campus in Midlothian, gets ready to open the doors to its first tenant.

The first ever global Zoonotic TB roadmap

A roadmap to combat Zoonotic Tuberculosis was launched last week at the Union World Conference on Lung Health in Mexico.

Defra’s Chief Scientific Adviser talked at The Roslin Institute

Professor Ian Boyd from the Department of Environment, Food and Rural Affairs (Defra) has given a seminar at The Roslin Institute.

TC BioPharm announce strategic collaboration with bluebird bio to develop gamma delta T Cell capabilities

bluebird bio and Scottish immunotherapy company TC BioPharm announce a strategic collaboration and license agreement focused on gamma delta CAR-T cells for cancer immunotherapy.

Consumers set to play role in livestock genetics

Consumers around the UK could soon be playing an important role in livestock genetics, thanks to a unique mobile sensory lab being unveiled this week by Scotland’s Rural College.

New poultry facility in Ethiopia explores genetic diversity

Cutting edge research and development programmes at the "Incubated Worlds" poultry facility will be lead by the Centre for Tropical Livestock Genetics and Health - a strategic alliance of The University of Edinburgh (through The Roslin Institute), Scotlan...

Workshop shows commitment to make Goa rabies free

The workshop, hosted by the Department of Animal Husbandry and Veterinary Services, brought together stakeholders from across government departments, fostering a One Health perspective on rabies control

Superbug study spots link between people and animals

A team led by the University of Edinburgh’s Roslin Institute analysed the entire genetic make-up of more than 800 strains of S. aureus that were isolated from people and animals.

Ideas Become Legend: achievements with an impact

This week, The Roslin Institute is taking part in VisitScotland’s Legends campaign, showcasing Edinburgh’s strength in the life sciences section. Join the conversation #IdeasBecomeLegend

Synpromics named among the top 50 fastest growing technology companies in the UK

Synpromics, the leader in gene control, is delighted to announce that it has been ranked 12th in the Deloitte ‘UK Technology Fast 50’ at the annual awards ceremony in London last night.

Study could explain higher rates of human E. coli infection in Scotland

A subtype of E. coli O157 found in cattle may be responsible for higher rates of severe human infection in Scotland, report suggests.

All 18 Scottish Universities pledge financial support to Converge

The 2019 Converge programme is now open for applications and the Converge search is on for new academic entrepreneurs.

Researchers play key role in Science Festival

Experts from across the University of Edinburgh are sharing their knowledge with audiences at Edinburgh Science from 6 to 21 April.

Launch of Legends Legacy Network

The next evolution of the award winning Ideas Become Legend campaign was announced with a network of 15 organisations across Scotland.

Synpromics deal significantly exceeds returns for investors including Calculus and Scottish Investment Bank

Synpromics has been bought by AskBio, the American pioneer in gene therapeutics with support from Calculus Capital and the Scottish Investment Bank.

Wild animals’ immune systems decline with age, sheep study finds

It is well established that weakened immune systems in old age affect people’s health and fitness, but a study suggests that it is also an issue for wild animals.

Climate lessons could aid antibiotics challenge

Efforts to control the rise of antibiotic resistance could be informed by lessons learned from the climate change crisis, research suggests.

Royal Commission Fellowship a first for Ingenza

1851 Royal Commission Fellowship has funded innovative doctoral research with commercial potential for Dr Stephen McColm to develop an enhanced DNA assembly approach based on the company’s proprietary inABLE® technology.

Midlothian Council declares climate emergency

Midlothian Council has declared a ‘Climate Emergency’ with the aim of making the council’s activities net-zero carbon by 2030.

Cow DNA offers clues to longer life

Research into the DNA of Scottish cows could help humans live longer and healthier lives, announce SRUC scientists.

Facility to boost research into animal and human health

The Large Animal Research and Imaging Facility has opened at Easter Bush Campus and will provide unprecedented insights into livestock and human health.

Europe’s first regional data innovation centre hosted in Edinburgh

Hewlett Packard Enterprise powers the Edinburgh International Data Facility with software, HPC and AI solutions.

Cambrex completes major expansion of solid form screening facility in Midlothian

Cambrex has announced the completion of an expansion of its solid form screening and crystallization process development facility at Edinburgh Technopole.

Study sheds light on how food bugs infect cells

Research shows how some gut bacteria with long corkscrew-like structures stick to cells and help cause disease.

The Scottish Life Sciences Covid-19 Strategic Response Plan launched

Ahead of the annual Life Sciences Conference this week (3rd December), the sector's Industry Leadership Group has launched the Scottish Life Sciences Covid-19 Strategic Response Plan.

Genetic code could predict severity of Covid-19 in patients

Researchers are to study the genetic blueprints of severely ill Covid-19 patients to find out why the disease affects some more seriously than others and suggest potential treatments.

Comic book helps communicate benefits of genetic gain in tropical livestock

A new comic book developed by the Centre for Tropical Livestock Genetics and Health (CTLGH) is being used to inspire young people about the power of genetics and how it can provide solutions in the real world.

Microbiome science aims to tackle biggest challenges

New research and innovation collaboration networks could help to make the most of the UK’s world-renowned microbiome expertise.

Aspirational female founders shortlisted in AccelerateHER Awards

Twelve aspirational female company founders shortlisted as finalists in the AccelerateHER Awards 2021 including two Midlothian-based biotech businesses.

A COVID story from the heart of Midlothian

A glimpse of the expertise, flexibility and resources which business within Midlothian Science Zone have so far demonstrated during the Covid crisis, while delivering on ongoing projects and partnerships.

EPP accredited by Living Wage Foundation

Edinburgh Pharmaceutical Processes, a GLP Contract Research Laboratory in Midlothian Science Zone, is accredited by Living Wage Foundation UK.

Antibiotic resistance predates modern medicine

Research has shown that bacteria resistant to antibiotics commonly infected hedgehogs some 200 years ago, long before they became a widespread problem for modern medicine.

TC BioPharm to participate in Advanced Therapies Week

TC BioPharm Limited, a clinical stage biotechnology company, will be participating in the Treating Cancer and Covid session at this expo for companies in the cell and gene therapy sector.

MSZ Business Forum meet an entrepreneur progressing cancer research

Midlothian Business Forum welcomed an award-winning entrepreneur Ishani Malhotri, founder and CEO of Carcinotech to learn more about her entrepreneurial journey and success in the manufacturing of 3D cancer research models to enable accurate testing and t...